Acadian Asset Management »

Eagle Pharmaceuticals shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 7.2k 3.63
2024-06-30 $147k 26k 5.57
2024-03-31 $274k 52k 5.22
2023-09-30 $3.7M 237k 15.76
2023-06-30 $4.4M 225k 19.42
2023-03-31 $6.1M 215k 28.35
2022-12-31 $6.8M 232k 29.21
2022-09-30 $8.2M 311k 26.42
2022-06-30 $8.3M 187k 44.43
2022-03-31 $6.9M 140k 49.45
2021-12-31 $5.4M 106k 50.89
2021-09-30 $7.2M 129k 55.73
2021-06-30 $11M 262k 42.80
2021-03-31 $8.9M 213k 41.74
2020-12-31 $8.0M 172k 46.58
2020-09-30 $7.2M 169k 42.48
2020-06-30 $5.7M 118k 47.98
2020-03-31 $4.0M 88k 46.00
2019-12-31 $1.4M 24k 60.08
2019-09-30 $1.7M 31k 56.57
2019-06-30 $1.9M 35k 55.66
2019-03-31 $210k 4.1k 50.63
2018-12-31 $121k 3.0k 40.23
2018-09-30 $115k 1.7k 69.61
2017-12-31 $201k 3.8k 53.44
2017-09-30 $456k 7.6k 59.71